No abstract

No abstract

A general method for the synthesis of 1,3,5-trisubstituted 1,2,4-triazoles has been developed from reaction of amidrazones with ethyl azodicarboxylate and triethylamine (Mitsunobu reagent) in EtOH. This highly regioselective one-pot process provides rapid access to highly diverse triazoles. The reaction was explained, based on Mitsunobu reagent oxidizing ethanol to acetaldehyde, which would then react with amidrazones to give the substituted 3-methyltriazoles. A [2 + 3] cycloaddition reaction between two oxidized forms of amidrazones produced the second type of triazoles. X-ray structure analyses proved the structure of each type of product.

(Z)‐2‐(2‐Oxoindolin‐3‐ylidene)‐2‐(substituted amino)acetonitriles, 2‐thioxoimidazolidine‐1‐carbothioamides, and 2‐thioxotetrahydropyrimidine‐1(2H)‐carbothioamides were synthesized via conventional thermal or microwave‐assisted reaction of isatylidene malononitrile with N,N″‐1,ω‐alkanediyl‐bis‐[N′‐organylthiourea] derivatives. Rationale for these conversations involving the nucleophilic addition on the dicyanomethylene carbon atom and intramolecular heterocyclization of the title compounds is presented. The structure of the (Z)‐2‐(2‐oxoindolin‐3‐ylidene)‐2‐(phenylamino)acetonitrile has been confirmed by the X‐ray analysis.

A synthesis of benzo[ e][1,2,4]triazines and 1,2,4-triazolospiro[4,5]deca-2,6,9-trien-8-ones has been developed from reactions of amidrazones with 2-chloro-1,4-benzoquinone in EtOAc containing 0.5 mL of piperidine. This highly regioselective and one-pot process provided rapid access to 1,2,4-triazolospiro[4,5]deca-2,6,9-trien-8-ones (60%–70%) and benzo[ e][1,2,4]triazines (11%–18%). On reacting amidrazones with 5-hydroxy-1,4-naphthoquinone in an EtOAc/piperidine mixture, the reaction proceeded to give 5-hydroxy-2-(piperidin-1-yl)naphthalene-1,4-dione. The structures of the isolated products were proved by infrared, NMR (2D-NMR), mass spectra, and elemental analyses in addition to X-ray structure analysis. The reaction mechanisms are discussed. The anticancer screening of selected compounds showed broad-spectrum anticancer activity against most melanoma cancer cell lines, ovarian cancer OVCAR-3, central nervous system cancer SF-295 and U251, non-small cell lung cancer NCI-H23, renal cancer SN12C, and colon cancer HCT-15 and HCT-116. The selected compounds exhibited moderate to weak anticancer activity to other cell lines.